Research Topics
| M E RolandSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Kidney and liver transplantation in HIV-infected patients: case presentations and reviewMichelle E Roland
Department of Medicine, University of California, San Francisco, San Francisco, California, USA
AIDS Patient Care STDS 17:501-7. 2003....- Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposureM E Roland
University of California at San Francisco, Div of AIDS, Dept of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
J Infect Dis 184:1608-12. 2001..The treatment history, particularly nonuse of a class of antiretroviral drugs, can be used to predict drug resistance... - Review of solid-organ transplantation in HIV-infected patientsMichelle E Roland
Department of Medicine, University of California, San Francisco, California, USA
Transplantation 75:425-9. 2003 - Seroconversion following nonoccupational postexposure prophylaxis against HIVMichelle E Roland
Positive Health Program at San Francisco General Hospital, California, USA
Clin Infect Dis 41:1507-13. 2005..We sought to describe the occurrence and circumstances of HIV seroconversion following nonoccupational PEP... - HIV RNA testing in the context of nonoccupational postexposure prophylaxisMichelle E Roland
Positive Health Program at San Francisco General Hospital, Department of Medicine, University of California, San Francisco, CA 94110, USA
J Infect Dis 190:598-604. 2004..The specificity and positive predictive value of human immunodeficiency virus (HIV) RNA assays have not been evaluated in the setting of postexposure prophylaxis (PEP)... - Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patientsMichelle E Roland
Positive Health Program Department of Medicine University of California, San Francisco Ward 84, San Francisco General Hospital 995 Potrero Ave San Francisco, CA 94110, USA
Arch Intern Med 163:1773-8. 2003 - Solid organ transplantation is a reality for patients with HIV infectionMichelle E Roland
Department of Medicine, University of California, Positive Health Program AIDS Division at San Francisco General Hospital, Ward 84, Building 80, 995 Potrero Avenue, San Francisco, CA 94110, USA
Curr HIV/AIDS Rep 3:132-8. 2006..Because important patient selection and clinical management questions remain, it is critical that ongoing studies are completed quickly... - Postexposure prophylaxis after sexual exposure to HIVMichelle E Roland
Positive Health AIDS Program at San Francisco General Hospital, University of California, San Francisco, California 94110, USA
Curr Opin Infect Dis 20:39-46. 2007.... - Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP StudyJ O Kahn
Positive Health Program, Dept of Medicine, University of California San Francisco, at San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
J Infect Dis 183:707-14. 2001..PEP, after nonoccupational HIV exposure, is feasible for persons at risk for HIV infection... - HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomesM E Roland
University of California, San Francisco, CA, USA
Am J Transplant 8:355-65. 2008.... - Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipientsL A Frassetto
Department of Medicine, Clinical Research Center, University of California, San Francisco, CA, USA
Am J Transplant 7:2816-20. 2007..Changes in antiretroviral therapy should be carefully managed to avoid insufficient immunosuppression or toxicity due to drug interactions... - Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipientsJ T Carter
Department of Surgery, University of California, San Francisco, California, USA
Am J Transplant 6:753-60. 2006.... 
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsC S Coffin
Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Am J Transplant 10:1268-75. 2010..Combination HBIG and antivirals is effective as prophylaxis with no clinical evidence of HBV recurrence but low-level HBV DNA is detectable in approximately 50% of recipients...- [Comprehensive guidelines translate research findings into clinical policy for HIV-infected transplant candidates and recipients.]Michelle E Roland
Enferm Infecc Microbiol Clin 23:331-4. 2005 - Responding to organ failure in HIV-infected patientsMichelle E Roland
AIDS Division, Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, USA
N Engl J Med 348:2279-81. 2003 - Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy studyPeter G Stock
Department of Surgery, Division of Transplantation, University of California, San Francisco, California 94143 0780, USA
Transplantation 76:370-5. 2003.... - Evolving clinical strategies for transplantation in the HIV-positive recipientPeter G Stock
Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
Transplantation 84:563-71. 2007..This overview will describe the evolving clinical strategies that have resulted in good outcomes after solid organ transplantation in the HIV-positive recipient... - A model for communitywide delivery of postexposure prophylaxis after potential sexual exposure to HIVMichelle E Roland
Sex Transm Dis 34:294-6. 2007 - Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virusSteven D Pinkerton
Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI 53202, USA
Arch Intern Med 164:46-54. 2004..CONCLUSIONS: For this study population, HIV PEP was cost-effective by conventional standards and cost-saving for persons seeking PEP after male-male receptive anal intercourse... - Solid organ transplantation: referral, management, and outcomes in HIV-infected patientsMichelle E Roland
University of California, San Francisco, USA
AIDS Read 16:664-8, 675-8. 2006..Timely referral for transplant evaluation will prevent unnecessary mortality during the pre-transplant evaluation process... - Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behaviorJeffrey N Martin
Department of Epidemiology and Biostatistics, the Center for AIDS Prevention Studies, and San Francisco, California 94105, USA
AIDS 18:787-92. 2004..Coupled with prior safety and feasibility data, this lack of behavioral disinhibition suggests that use of PEP should be routinely considered following high-risk sexual exposures... - Enhancing the potential benefits of HIV post-exposure prophylaxisMichelle E Roland
AIDS 20:1889-90. 2006 - Liver transplantation in HIV-infected recipientsMichelle E Roland
Department of Medicine, Positive Health Program, AIDS Division, University of California, San Francisco, CA, USA
Semin Liver Dis 26:273-84. 2006.... - Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantationNorah A Terrault
Department of Medicine, University of California at San Francisco, San Francisco, CA 64143 0538, USA
Liver Transpl 12:801-7. 2006..In HIV-HBV coinfected patients undergoing LT, HBV recurrence is successfully prevented with combination prophylaxis using HBIG and antivirals... - Solid-organ transplantation in HIV-infected patients in the potent antiretroviral therapy eraMichelle E Roland
University of California Positive Health Program (HIV/AIDS Division, San Francisco General Hospital, San Francisco, CA, USA
Top HIV Med 12:73-6. 2004..This article summarizes a presentation by Michelle E. Roland, MD, at the February and April 2004 International AIDS Society-USA courses in Atlanta, Los Angeles, and Chicago... - Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipientsLynda Frassetto
Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
Transplantation 80:13-7. 2005..Medication changes must be carefully managed to avoid insufficient immunosuppression or toxicity resulting from drug interactions... - Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United StatesSteven D Pinkerton
Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53202, USA
AIDS 18:2065-73. 2004..To evaluate the cost-effectiveness of HIV postexposure prophylaxis (PEP) following sexual or injection-related exposures in 96 metropolitan statistical areas in the United States (MSA)...
Research Grants
- The Social Context of HIV Post-Exposure ProphylaxisMichelle Roland; Fiscal Year: 2006..abstract_text> ..